Myricx Bio, a cancer therapy spinout based on research from the Crick and Imperial College London, has raised £90 million to start the clinical development of cancer treatments. https://lnkd.in/e_afx7YN
The Francis Crick Institute’s Post
More Relevant Posts
-
Improving cancer immunotherapy in prostate cancer by modulating T cell function through targeting the galectin-1 Frontiers https://lnkd.in/g9gjAq-Q
Frontiers | Improving cancer immunotherapy in prostate cancer by modulating T cell function through targeting the galectin-1
frontiersin.org
To view or add a comment, sign in
-
Check out our coverage of the Binaytara Foundation's conferences like this Translational Science🧪 Update of Precision Oncology Methods in 🫁Lung Cancer piece ⬇️ https://lnkd.in/gfW5Vjps #lungcancer #Oncology #cancernews #medicalnews #precisiononcology #cancer
Translational Science Update of Precision Oncology Methods in Lung Cancer
https://thecancernews.org
To view or add a comment, sign in
-
🌟 Exciting breakthroughs in cancer research! 🧬 Discover the potential of Cancer Cell Membrane-Coated Nanocarriers in revolutionizing cancer diagnosis and treatment. 🚀 This innovative approach holds promise for targeted therapies and personalized medicine. Stay ahead in the field—check out the insightful article on Pharma Focus America! 👉 Link: https://lnkd.in/gWHvxgKH #CancerResearch #InnovationInMedicine #Nanotechnology #PrecisionMedicine #MedicalAdvancements #HealthcareInnovation #BiomedicalEngineering #Oncology #TherapeuticInnovation #PharmaFocusAmerica #ScienceBreakthroughs
conventional cancer therapy | nanoparticles in cancer treatment
pharmafocusamerica.com
To view or add a comment, sign in
-
Director of Business Development @ Labcorp Drug Development | Preclinical Oncology, Immuno-oncology | Strategy | Partnerships | Scientist | Speaker | Mentor | TEDWomen
New approach to pancreatic cancer treatment expands therapeutic possibilities, shows promise for increased survival. #pancreaticcancer #preclinical #preclinicalresearch #pancreatic #oncology #oncologyresearch https://lnkd.in/gzBXwDYb
New approach to pancreatic cancer treatment expands therapeutic possibilities, shows promise for increased survival
medicalxpress.com
To view or add a comment, sign in
-
Good stuff coming from the University of Pittsburgh showing us the continued progress in our collective fight to provide the best care possible for patients with cancer. Cancer rehabilitation specialists (PTs, OTs, SLPs, etc) play such a pivotal role in providing the best standard of care. That’s our mission at ReVital Cancer Rehabilitation. #together #optimal #patientcare #cancerrehab #research #oncology
A recent study from the University of Pittsburgh reveals how adoptive therapy–the transfer of a defined population of tumor-infiltrating-lymphocytes (TIL) from patients' own tumors–could revolutionize cancer treatments. Learn how the UPMC Enterprises team supports the latest in innovative patient care through their latest funding initiative: https://lnkd.in/dziG-jke
Pioneering the Future of Personalized Cancer Treatment | UPMC Enterprises
https://enterprises.upmc.com
To view or add a comment, sign in
-
Our latest news.
Additional Funding Awarded to Howard University Researcher to Enhance Effectiveness of Immunotherapy in Gastric Cancer #degregoriofamilyfoundation #gastriccancer #gastroesophagealcancer #esophagealcancer #howarduniversity https://lnkd.in/ePqCZrYE
Additional Funding Awarded to Howard University Researcher to Enhance Effectiveness of Immunotherapy in Gastric Cancer
prnewswire.com
To view or add a comment, sign in
-
Breakthroughs in cancer research have led to the development of next-generation ERK pathway inhibitors, crucial for treating various types of tumors, including melanoma and pancreatic cancer. Precision medicine is accelerating the identification of novel targets in the ERK pathway through the analysis of patient data, paving the way for improved survival rates. Learn how PDX models are used for screening and assessing the safety and efficacy of these inhibitors in our blog. #CancerResearch #PrecisionMedicine #ERKPathway #ERK #Melanoma #PancreaticCancer #PDX #Cancer #OncologyResearch #Oncology #Tumor https://hubs.li/Q021C34b0
ERK at Work - Targeting the ERK Pathway in Cancer
blog.championsoncology.com
To view or add a comment, sign in
-
📌 PragmaTIL | Press release ▶ The kick-off press release of the #EUfunded PragmaTIL has just been published! ▶ The PragmaTIL trial aims to optimize treatment of #cancer patients with Tumour-Infiltrating Lymphocytes Adoptive #CellTherapy (TIL-ACT) and substantially expand and improve the #clinical implementation of this treatment modality in academic hospitals. To this end, treatment related toxicities, associated to high-dose #interleukin 2 (HD-IL-2) required for expansion and activation of #TILs will be reduced while maintaining efficacy. ▶ ASPHALION, in charge of the Regulatory part of the project, is focusing on the submission of the #clinicaltrial and the #safety management plan. 📧 For further information, you can contact us at: [email protected] ➕ To learn more about #PragmaTIL, please visit: www.pragmatil.eu #CTIS #Safety #RA #HORIZON #EU #RegulatoryAffairs #EquitableAccess #Patientcentered #DisruptiveInnovativeTherapy #WeAreAsphalion #WeCare #KnowledgeFromExperience
The PragmaTIL Project seeks to enhance TIL-based cell therapy for melanoma, lung, and cervical cancer patients. This trial is funded by the European Union in the framework of the European Commission’s Cancer Mission, under the Horizon Europe: Research and Innovation Actions program. Fundación ”la Caixa” Vall d'Hebron Institute of Oncology (VHIO) Gustave Roussy The Netherlands Cancer Institute Unicancer Region Hovedsraden Karolinska Institutet Sheba Medical Center, Tel Hashomer ASPHALION Seintinelles Innovandum Health BCN HEALTH #HrizonEU #TILTherapy #PragmaTIL #Oncology https://lnkd.in/dkAVyXrk
The PragmaTIL project aims to optimize cell therapy with TILs in patients with melanoma, lung cancer, and cervical cancer
https://pragmatil.eu
To view or add a comment, sign in
-
Immuno-oncology has been changing the way we think about and interact with cancer, with a wide variety of talent working to deliver on new & improved solutions. However, it can often be difficult for companies to find the relevant skills & experience needed for such a young sector. In today's blog, Jamie Gould takes us through his observations in immuno-oncology, and how companies can focus their sights on the perfect talent. Click below to read more! #ExecutiveSearch #LifeSciences #Oncology #Immunotherapy #BecauseTalentMatters
Fuelling the future of immuno-oncology talent - The RSA Group
https://www.thersagroup.com
To view or add a comment, sign in
Editor-in-Chief Stem Cell Reviews and Reports at Springer
1moHIGH POWER!